Search research articles
Contact Us
Filters
Showing results (191-200 of 321) with videos related to
Page
of 33
Sort By:
Journal of Neuro-Oncology
|
November 30, 2018
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide
Michael Dworkin, William Mehan, Andrzej Niemierko, et al.
Plos One
|
April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications
Dora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
The Oncologist
|
June 11, 2020
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial
Jorg Dietrich, Laura Versmee, Jan Drappatz, et al.
The Oncologist
|
August 12, 2018
Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study
K Ina Ly, Derek H Oakley, Alexander B Pine, et al.
Blood
|
April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report
Sigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma
Gregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.
Scientific Reports
|
September 15, 2020
An integrated RF-receive/B<sub>0</sub>-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T
Morteza Esmaeili, Jason Stockmann, Bernhard Strasser, et al.
Neuro-Oncology
|
October 28, 2020
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
Jian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Journal of Neuro-Oncology
|
December 16, 2014
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study
Milan G Chheda, Patrick Y Wen, Fred H Hochberg, et al.
Nature Medicine
|
August 20, 2013
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
Kyrre E Emblem, Kim Mouridsen, Atle Bjornerud, et al.
Page
of 33
Search research articles
Search
Showing results (191-200 of 321) with videos related to
Sort By:
Page
of 33
Journal of Neuro-Oncology
|
November 30, 2018
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide
Michael Dworkin, William Mehan, Andrzej Niemierko, et al.
Plos One
|
April 12, 2011
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications
Dora Dias-Santagata, Quynh Lam, Kathy Vernovsky, et al.
The Oncologist
|
June 11, 2020
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial
Jorg Dietrich, Laura Versmee, Jan Drappatz, et al.
The Oncologist
|
August 12, 2018
Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study
K Ina Ly, Derek H Oakley, Alexander B Pine, et al.
Blood
|
April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report
Sigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma
Gregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.
Scientific Reports
|
September 15, 2020
An integrated RF-receive/B<sub>0</sub>-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T
Morteza Esmaeili, Jason Stockmann, Bernhard Strasser, et al.
Neuro-Oncology
|
October 28, 2020
Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
Jian Teng, Seyedali Hejazi, Lotte Hiddingh, et al.
Journal of Neuro-Oncology
|
December 16, 2014
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study
Milan G Chheda, Patrick Y Wen, Fred H Hochberg, et al.
Nature Medicine
|
August 20, 2013
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
Kyrre E Emblem, Kim Mouridsen, Atle Bjornerud, et al.
Page
of 33